Moran Wealth Management
ANAB icon

Moran Wealth Management’s AnaptysBio ANAB Stock Holding History

Moran Wealth Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,981
Closed -$269K – 502
2026
Q2 		$269K Sell
3,981
-83
-2% -$5.03K 0.01% 472
2026
Q1 		$225K Buy
+4,064
New +$219K 0.01% 455

Other funds holding ANAB

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $9.18B AUM 10.37% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Moran Wealth Management's ANAB Position: Q3 2026 in Review

Moran Wealth Management sold out of AnaptysBio (ANAB) in Q3 2026, closing a stake of 3,981 shares — an estimated $269K sold.

Moran Wealth Management first reported a position in ANAB in Q1 2026 and held it in 2 quarters. The position peaked at $269K in Q2 2026. 99 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Moran Wealth Management reported no remaining AnaptysBio position as of Q3 2026 after selling out during the quarter.
  • Moran Wealth Management sold 3,981 AnaptysBio shares in Q3 2026, an estimated $269K.
  • Moran Wealth Management first reported a position in AnaptysBio in Q1 2026 and held it in 2 quarters.
  • Moran Wealth Management's AnaptysBio position peaked at $269K in Q2 2026.
  • 99 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Moran Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.